spot_img
3.8 C
London
HomeInvestors HealthBioNTech stock slips on COVID vaccine deals (update) (BNTX:NASDAQ)

BioNTech stock slips on COVID vaccine deals (update) (BNTX:NASDAQ)


BioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine

Thomas Lohnes/Getty Images News

Update 8.38 AM EST: Adds details about Penn settlement

BioNTech (NASDAQ:BNTX) announced Friday two separate agreements worth more than $1B with the National Institutes of Health (NIH) and the University of Pennsylvania to resolve royalty and other claims related to sales of



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here